Man Group PLC Pyxis Oncology, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Man Group PLC holds 52,954 shares of PYXS stock, worth $226,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,954
Previous 147,180
64.02%
Holding current value
$226,643
Previous $626,000
72.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
92Shares Held
29.4MCall Options Held
134KPut Options Held
5K-
Deep Track Capital, LP Greenwich, CT4.18MShares$17.9 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.86MShares$16.5 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$10.4 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.66MShares$7.12 Million2.23% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $150M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...